当前位置:首页 - 行情中心 - 科拓生物(300858) - 财务分析 - 现金流量表

科拓生物

(300858)

  

流通市值:33.77亿  总市值:45.45亿
流通股本:1.96亿   总股本:2.63亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金85,551,904.77391,643,650.96281,288,476.97165,079,717.13
  收到的税费返还-25,700,190.89606,711.26606,711.26
  收到其他与经营活动有关的现金4,426,674.7430,531,315.0812,481,235.577,500,452.04
  经营活动现金流入小计89,978,579.51447,875,156.93294,376,423.8173,186,880.43
  购买商品、接受劳务支付的现金33,783,289.32150,225,705.34106,574,576.9266,975,920.12
  支付给职工以及为职工支付的现金26,633,289.572,920,595.7152,243,964.2136,816,322.38
  支付的各项税费7,826,989.8447,549,137.2432,109,762.1822,995,866.63
  支付其他与经营活动有关的现金14,585,111.5353,738,078.0230,849,818.718,515,779.02
  经营活动现金流出小计82,828,680.19324,433,516.31221,778,122.01145,303,888.15
  经营活动产生的现金流量净额7,149,899.32123,441,640.6272,598,301.7927,882,992.28
二、投资活动产生的现金流量:
  收回投资收到的现金859,450,015.171,104,035,227.53976,191,724.42605,494,027.97
  投资活动现金流入小计859,450,015.171,104,035,227.53976,191,724.42605,494,027.97
  购建固定资产、无形资产和其他长期资产支付的现金33,489,752.09296,122,796.16245,323,159.4174,382,740.74
  投资支付的现金723,277,977.17896,879,565.06770,949,946.76501,410,604.28
  投资活动现金流出小计756,767,729.261,193,002,361.221,016,273,106.16675,793,345.02
  投资活动产生的现金流量净额102,682,285.91-88,967,133.69-40,081,381.74-70,299,317.05
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金-39,524,267.739,524,267.7-
  支付其他与筹资活动有关的现金416,094889,269.79842,488.34658,865
  筹资活动现金流出小计416,09440,413,537.4940,366,756.04658,865
  筹资活动产生的现金流量净额-416,094-40,413,537.49-40,366,756.04-658,865
四、汇率变动对现金及现金等价物的影响-4.64-19.81-52.829.89
五、现金及现金等价物净增加额109,416,086.59-5,939,050.37-7,849,888.81-43,075,179.88
  加:期初现金及现金等价物余额99,646,317.1105,585,367.47105,585,367.47105,585,367.47
  期末现金及现金等价物余额209,062,403.6999,646,317.197,735,478.6662,510,187.59
补充资料:
  净利润-94,519,402.43-41,205,063.04
  资产减值准备-261,600.94--
  固定资产和投资性房地产折旧-30,214,819.91-14,599,665.27
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-30,214,819.91-14,599,665.27
  无形资产摊销-2,807,900.78-1,350,250.11
  长期待摊费用摊销-630,674.29-630,674.29
  固定资产报废损失-17,695.68--
  公允价值变动损失--1,619,799.22--956,219.16
  财务费用--19,178,409.55--9,545,196.61
  投资损失--2,180,536.37--1,298,927.79
  递延所得税--7,268,453.26-1,641,841.78
  其中:递延所得税资产减少--7,649,097.81-1,696,347.96
    递延所得税负债增加-380,644.55--54,506.18
  存货的减少--128,272.65-2,525,110.09
  经营性应收项目的减少--26,416,233.49--16,885,042.87
  经营性应付项目的增加-46,768,949.89--6,353,462.13
  其他-1,265,176--
  现金的期末余额-99,646,317.1-62,510,187.59
  减:现金的期初余额-105,585,367.47-105,585,367.47
  现金及现金等价物的净增加额--5,939,050.37--43,075,179.88
公告日期2026-04-222026-04-222025-10-222025-08-20
审计意见(境内)标准无保留意见
TOP↑